India Resurgence Fund (IndiaRF), backed by Piramal Enterprises and Bain Capital Credit, is investing about $144 million (Rs 992 crore) in New Delhi-based drug firm Panacea Biotec, per an announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
